Latest
-
Can This Fallen Biotech Be Revived?
investing I've been sorely tempted to sell my Gilead shares. But now that they're cheaper, maybe I should buy more.
investing -
A Takeover Boosts My Portfolio
investing But the merger left me sitting on a ton of cash that’s earning almost nothing.
investing -
This Stumbling Biotech Stock Still Has a Lot of Promise
investing Gilead Sciences' robust product pipeline should turn things around.
investing -
My Portfolio's Uninvited Guests
investing A well-considered spin-off can increase the value of both parent and child by allowing each to focus on a narrower set of goals.
investing -
Why Is My Portfolio Lagging? Blame It on 2015
investing A portfolio without FANGs was doomed to have trouble last year.
investing -
Learning From My Misguided Attempt to Beat the Market
Investor Psychology Selling quality stocks was just one of the mistakes.
Investor Psychology -
How Doing Nothing Can Pay Off for Investors
investing For the three-month period during which I essentially ignored my investments, the Practical Investing portfolio rose 10%.
investing -
AV Homes: A Cheap Stock With Rich Potential
investing This small homebuilder's first-quarter results were impressive, with big gains in number of dwellings sold and other key measures.
investing -
Biotech Giant Gilead Sciences Goes on Sale
investing Gilead Sciences stock was selling for a mere 7 times estimated 2016 earnings when I snapped up 150 shares.
investing
